Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 1;147(5):500-506.
doi: 10.1093/ajcp/aqx029.

Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases

Melanie D Fox  1 , Li Xiao  1 , Miao Zhang  1 , Ashish M Kamat  2 , Arlene Siefker-Radtke  3 , Li Zhang  4 , Colin P Dinney  2 , Bogdan Czerniak  1 , Charles C Guo  1
Affiliations

Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases

Melanie D Fox et al. Am J Clin Pathol. .

Abstract

Objectives: Plasmacytoid urothelial carcinoma (PUC) of the bladder is a rare histologic variant. We retrospectively analyzed a large series of bladder PUC from a single institution.

Methods: The patients consisted of 44 men and five women with a mean age of 62 years (range, 45-86 years).

Results: PUC was pure in 23 cases and mixed with other histologic types in 26 cases. All PUCs diffusely invaded the bladder wall. Most PUCs lacked immunoreactivity for the retinoblastoma (RB) gene protein (12/32) and E-cadherin (8/30). Of the 44 patients with follow-up information, 25 died of PUC at a mean of 23 months, whereas 19 patients were alive at a mean of 22 months.

Conclusions: Our findings support that bladder PUC is a highly aggressive disease. The lack of E-cadherin expression in PUCs may underlie the distinct discohesive histologic appearance, and abnormal function of the RB gene may be implicated in the development of PUC.

Keywords: Bladder cancer; E-Cadherin; Immunohistochemistry; Plasmacytoid urothelial carcinoma; Retinoblastoma gene.

PubMed Disclaimer

Substances